Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

NCT01572662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

201

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Acute Myeloid Leukemia
Acute Lymphocytic Leukemia
Chronic Myeloid Leukemia
Chronic Lymphocytic Leukemia
Myeloproliferative Diseases
Non-Hodgkins Lymphoma
Hodgkins Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome

Interventions

DRUG: Fludarabine monophosphate
DRUG: Busulfan
PROCEDURE: Stem Cell Infusion
DRUG: Tacrolimus
DRUG: Methotrexate
DRUG: G-CSF

Sponsor

M.D. Anderson Cancer Center